secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2022-07-19T23:59:59+00:00
Accession:  0001628280-22-019114
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Martin S. Brown Jr., former Brown-Forman director, joins Cumberland Pharmaceuticals board effective July 15, 2022
--------------------------------------------------------------------------------

- Martin S. Brown Jr., attorney at Adams & Reese LLP, appointed to board effective July 15, 2022.
- Brown previously served 10 years on Brown-Forman Corporation's board; has 30 years legal experience.
- No arrangements or family relationships with directors or execs; will receive standard non-executive director compensation.
- He has not been named to any board committees yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000162828022019114/0001628280-22-019114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000162828022019114/cpix-20220719.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-019114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer